Close Menu

NEW YORK — Spanish diabetes testing firm Patia said today that it has signed an agreement to market its type 2 diabetes (T2D) risk test in the US through GX Sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.